Only a tiny percentage of adult cancer patients participate in clinical trials, research that is the single most important component of medical research. Brain tumor patients have a lot of factors to evaluate when considering joining a clinical trial. Here are four perspectives from the Brains for the Cure video library.
Wish it was easier to stay current with all the news in the brain tumor community? Welcome to the first edition of our weekly collection of news, links, and articles curated especially for patients and caregivers. Have an article you’d like us to include? Please let us know here.
Duke Chronicle, Feb 18, 2019
Researchers at the Bellamkonda Lab at Duke University have created a device that “tricks” brain tumors into moving to areas of the brain that are more accessible to surgeons. Known as a “Tumor Monorail,” the device has been fast-tracked by the FDA and the team expects the device to be approved for human trials by the end of 2019.
Forbes, Feb 20, 2019
Doctors could soon use an exact 3D replica of their patient’s head to increase accuracy in radiotherapy treatments. A company based in Athens, Greece and San Antonio, Texas uses a CT scan to create a Personalized “PseudoPatient” that replicates the patient’s bone structure and external surface. Radiation treatments can then be tested and measured on the PseudoPatient before being performed on real patients.
Valley Roadrunner, Feb 21, 2019
Healthcare expenses contribute to over 60% of US Bankruptcy filings and even private insurance is far from a reliable solution. Charles Caratti discusses the problems facing patients in American today, and some potential solutions.
Genetic Literacy Project, February 19, 2019
Patients with a recurrence of glioblastoma who were given a drug known as a checkpoint inhibitor before surgery lived nearly twice as long as patients in a control group. According to researchers at UCLA, this study marks the first time that immunotherapy has been proven to be beneficial to glioblastoma patients.
News24, February 17, 2019
A British man diagnosed with glioblastoma in 2013 has completed his bucket list by visiting 18 countries and marrying his girlfriend of 25 years. Richard Preston is one of the 20% of patients to survive longer than 5 years, and now preparing festivities for his 50th birthday.